Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ACC Action Center

Preventive PCI versus optimal medical therapy only for vulnerable plaques

Marc Bonaca at the ACC24
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Read our summary of PREVENT

    Release date: 15 april 2024

Recommended
Details
Presenters
Comments
  • Overview

    ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Read our summary of PREVENT

    Release date: 15 april 2024

Schedule13 Dec 2024